scispace - formally typeset
S

Sittiruk Roytrakul

Researcher at Thailand National Science and Technology Development Agency

Publications -  440
Citations -  5719

Sittiruk Roytrakul is an academic researcher from Thailand National Science and Technology Development Agency. The author has contributed to research in topics: Medicine & Biology. The author has an hindex of 30, co-authored 349 publications receiving 4155 citations. Previous affiliations of Sittiruk Roytrakul include King Mongkut's University of Technology North Bangkok & Kasetsart University.

Papers
More filters
Journal ArticleDOI

In-gel digestion coupled with mass spectrometry (GeLC-MS/MS)-based salivary proteomic profiling of canine oral tumors

TL;DR: In this paper, the salivary proteome of dogs with early and late stage oral melanoma (EOM and LOM, respectively), oral squamous cell carcinoma (OSCC), benign oral tumors (BN), and periodontitis and healthy controls (CP), using an in-gel digestion coupled with mass spectrometry (GeLC-MS/MS).
Journal ArticleDOI

Endothelial Progenitor Cell Migration-Enhancing Factors in the Secretome of Placental-Derived Mesenchymal Stem Cells

TL;DR: This study studied the secretome profile of gestational tissue-derived MSCs and their effects on functions of endothelial progenitor cells (EPCs), another angiogenic cell type that plays an important role during the neovascularization.
Journal ArticleDOI

Nevirapine induces apoptosis in liver (HepG2) cells

TL;DR: There is a clear induction of apoptosis in response to NVP which suggests that NVP has significant cytotoxicity, over and above any cytot toxicity of metabolites and may contribute directly to patient hepatotoxicity.
Journal ArticleDOI

Gigantol Targets MYC for Ubiquitin-proteasomal Degradation and Suppresses Lung Cancer Cell Growth.

TL;DR: Gigantol was found to inhibit lung cancer proliferation through induction of GSK3β-mediated MYC ubiquitin-proteasome degradation and data suggest gigantol to be a promising candidate for novel strategy in inhibition of lung cancer.
Journal ArticleDOI

Serum coiled-coil domain containing 25 protein as a potential screening/diagnostic biomarker for cholangiocarcinoma.

TL;DR: Serum CCDC25 level may be a promising screening and diagnostic marker for the differential diagnosis of cholangiocarcinoma (CCA) tissues compared with adjacent normal tissues and among patients with CCA.